Melanie De Almeida
Hopes are up: A Second Phase III Trial for Alzheimer’s Disease
New Antibodies to Target the Respiratory Syncytial Virus
Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden!
UK Lays Down a Foundation for Physical Science Innovation
Biosimilars set to take on Oncology after a new Market Authorization
UK’s Joint Venture Bridging Academia and Industry is Ready for Kick-off
Roche doubles down in Fight against Antibiotic Resistance
A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa
New Immunotherapy Candidate receives FDA Fast Track Designation
Actelion’s key Drug linked to Deaths, prompting EMA Investigation
Suffering from House Dust Mite Allergy? A New Therapy is on its Way
Which European Country is Winning the Race in Clinical Development?
Labiotech UG, All Rights Reserved -
Send this to friend